Hostname: page-component-76fb5796d-zzh7m Total loading time: 0 Render date: 2024-04-27T10:07:49.477Z Has data issue: false hasContentIssue false

Neuroleptic-induced extrapyramidal symptoms are accompanied by cognitive dysfunction in schizophrenia

Published online by Cambridge University Press:  16 April 2020

M. Krausz
Affiliation:
Universitäts-Krankenhaus Hamburg—Eppendorf, Klinik für Psychiatrie und Psychotherapie, Martinistrae 52, 20246Hamburg, Germany
S.H. Moritz
Affiliation:
Universitäts-Krankenhaus Hamburg—Eppendorf, Klinik für Psychiatrie und Psychotherapie, Martinistrae 52, 20246Hamburg, Germany
D. Naber
Affiliation:
Universitäts-Krankenhaus Hamburg—Eppendorf, Klinik für Psychiatrie und Psychotherapie, Martinistrae 52, 20246Hamburg, Germany
M. Lambert
Affiliation:
Universitäts-Krankenhaus Hamburg—Eppendorf, Klinik für Psychiatrie und Psychotherapie, Martinistrae 52, 20246Hamburg, Germany
B. Andresen
Affiliation:
Universitäts-Krankenhaus Hamburg—Eppendorf, Klinik für Psychiatrie und Psychotherapie, Martinistrae 52, 20246Hamburg, Germany
Get access

Summary

Cognitive impairments in schizophrenics have been found to precede tardive dyskinesia and to co-exist with other motor deficits. However, little is yet known about the prevalence of cognitive disturbances in patients with neuroleptic-induced parkinsonism. From the literature on idiopathic parkinson, it was inferred that extrapyramidal symptoms (EPS) are accompanied by cognitive dysfunction. 85 schizophrenic in-patients were divided into EPS high and low scorers according to an established criterion (Simpson Angus Scale, cut-off score: 0.4). Cognitive impairments were assessed using a self-rating instrument measuring disturbances of information processing.

Patients with high EPS exhibited significantly elevated scores in six of ten cognitive and perceptual subscales (t = 2.1—3.1) as compared to low EPS patients. It is concluded that high EPS patients suffer from cognitive disturbances which are assumed to possess high relevance for both psycho-social and medical treatment. Cognitive problems may, when not considered, disturb compliance, insight of illness and transfer of learnt skills into everyday life.

Type
Original articles
Copyright
Copyright © Elsevier, Paris 1999

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Alexander, GEDeLong, MRStrick, PL. Parallel organization of functionally segregated circuits linking basal ganglia and cortex. Annu Rev Neurosci 1986 ; 9 : 357381.CrossRefGoogle ScholarPubMed
Brekke, JSRaine, AAnsel, MLencz, TBird, L. Neuropsychological and psychophysiological correlates of psychosocial functioning in schizophrenia. Schizophr Bull 1997 ; 23 : 1928.CrossRefGoogle Scholar
Brown, KWWhite, T. The psychological consequences of tardive dyskinesia. The effect of drug-induced parkinsonism and the topography of the dyskinetic movements. Br J Psychiatry 1991 ; 159 : 399403.CrossRefGoogle ScholarPubMed
Brown, KWWhite, TPalmer, D. Movement disorders and psychological tests of frontal lobe function in schizophrenic patients. Psychol M 1992 ; 22 : 6977.CrossRefGoogle ScholarPubMed
Brown, KWWhite, T. The influence of topography on the cognitive and psychopathological effects of tardive dykinesia. Am J Psychiatry 1992 ; 149 : 13851389.Google Scholar
Collegium Internationale Psychiatriae Scalarum Internationale Skalen für Psychiatrie. Weinheim: Beltz;1991.Google Scholar
Courchesne, ETownshend, JAkshoomoff, NASaitoh, OYeung-Courehesne, RLincoln, Aet alImpairment in shifting attention in autistic and cerebellar patients. Behav Neurosci 1994 ; 108 : 848865.CrossRefGoogle ScholarPubMed
Crane, GENaranjo, ERChase, C. Motor disorders induced by neuroleptics. A proposed new classification. Arch Gen Psychiatry 1971 ; 24 : 179184.CrossRefGoogle ScholarPubMed
Cuesta, MJPeralta, VJuan, JA. Abnormal subjective experiences in schizophrenia : its relationships with neuropsychological disturbances and frontal signs. Eur Arch Psychiatry Clin Neurosci 1996 ; 246 : 101105.CrossRefGoogle ScholarPubMed
Dech, HNorthoff, G. Zur Symptomatologie der Akathisie. Fortschritte Neurol Psychiatrie 1997 ; 65 : 232236.CrossRefGoogle Scholar
Durwen, HFCalabrese, PHolinka, BMarkowitsch, HJGehlen, W. Neuropsychologische Aspekte bei idiopathischem Morbus Parkinson. Fortschr Neurol Psychiatrie 1995 ; 63 : 6871.CrossRefGoogle Scholar
Fiez, JA. Cerebellar contributions to cognition. Neuron 1996 ; 16 : 1315.CrossRefGoogle Scholar
Frith, CDBloxham, CACarpenter, KN. Impairments in the learning and performance of a new manual skill in patients with Parkinson's disease. J Neurol Neurosurg Psychiatry 1986 ; 49 : 661668.CrossRefGoogle ScholarPubMed
Gardos, GCasey, DECole, JOPerenyi, AKocsis, EArato, Met alTen-year outcome of tardive dyskinesia. Am J Psychiatry 1994 ; 151 : 836841.Google ScholarPubMed
Goldberg, TEWeinberger, DR. Effects of neuroleptic medication on the cognition of patients with schizophrenia: a review of recent studies. J Clin Psychiatry 1996 ; 57 Suppl 9 : 6265.Google Scholar
Gotham, AMBrown, RGMarsden, CD. ‘Frontal’ cognitive function in patients with Parkinson's disease ‘on’ and ‘off’ levodopa. Brain 1988 ; 111 : 299321.CrossRefGoogle ScholarPubMed
Green, MF. What are the functional consequences of neurocognitive deficits in schizophrenia? Am J Psychiatry 1996 ; 153 : 321330.Google Scholar
Jahn, TMussgay, L. Die statistische Kontrolle möglicher Medikamenteneinflüsse in experimentalpsychologischen Schizophreniestudien: Ein Vorschlag zur Berechnung von Chlorpromazinäquivalenten. Z Klin Psychol 1989 ; 18 : 257267.Google Scholar
Kane, JMWoerner, MLieberman, J. Tardive dyskinesia: prevalence, incidence, and risk factors. J Clin Psychopharmacol 1988 ; 8 Suppl : 3137.CrossRefGoogle Scholar
Lees, AJSmith, E. Cognitive deficits in the early stages of Parkinson's disease. Brain 1983 ; 106 : 257270.CrossRefGoogle ScholarPubMed
Markowitsch, HJNeuropsychologie des Gedächtnisses Göttingen: Hogrefe; 1992.Google Scholar
Martin, PAlbers, M. Cerebellum and schizophrenia: a selective review. Schizophr Bull 1995 ; 21 : 241250.CrossRefGoogle ScholarPubMed
Moritz, SNaber, DKrausz, MLambert, MAndresen, BNeurokognitive Veränderungen in der Behandlung schizophrener Patienten unter ClozapinIn: Naber, DMüller-Spahn, F eds. Clozapin. Pharmakologie und Klinik eines atypischen Neuroleptikums Berlin: Springer; 1999. p. 90108.CrossRefGoogle Scholar
Simpson, GMAngus, JWS. A rating scale for extrapyramidal-side effects. Acta Psychiatr Scand 1970 ; 212 Suppl : 1119.CrossRefGoogle ScholarPubMed
Süllwold, LDie Selbstwahrnehmung defizitärer Störungen: Psychologische Aspekte des BasisstörungskonzeptesIn: Süllwold, LHuber, G eds. Schizophrene Basisstörungen Berlin: Springer; 1986. p. 138.CrossRefGoogle Scholar
Süllwold, L. Manual zum Frankfurter Beschwerde-Fragebogen (FBF) Berlin: Springer; 1991.CrossRefGoogle Scholar
Thomas, PMcGuire, R. Orofacial dyskinesia, cognitive function and medication. Br J Psychiatry 1986 ; 149 : 216220.CrossRefGoogle ScholarPubMed
Wegner, JTKane, JMWeinhold, PWoerner, MKinon, BLieberman, J. Cognitive impairment in tardive dyskinesia. Psychiatry Res 1985 ; 16 : 331337.CrossRefGoogle ScholarPubMed
World Health Organisation. SCAN — Schedules for Clinical Assessment in Neuropsychiatry. Genf: World Health Organization, Division of Mental Health; 1992.Google Scholar
Williams, RMAlagaratnam, WHemsley, DR. Relationship between subjective self-report of cognitive dysfunction and objective information-processing performance in a group of hospitalized schizophrenic patients. Eur Arch Psychiatry Neurol Sci 1984 ; 234 : 4853.CrossRefGoogle Scholar
Zerssen, DVParanoid-Depressivitäts-Skala Manual Weinheim: Beltz; 1976.Google Scholar
Submit a response

Comments

No Comments have been published for this article.